BOLD-100-001 (TRIO039): A phase 2 study of BOLD-100 in combination with FOLFOX in patients with advanced mCRC previously treated with FOLFOX/CAPOX—Efficacy and safety analysis.
| Autor: | Spratlin, Jennifer L., O'Kane, Grainne M., Oh, Do-Youn, Rha, Sun Young, McWhirter, Elaine, Elimova, Elena, Kavan, Petr, Choi, Moon Ki, Kim, Dae Won, Goodwin, Rachel Anne, Hecht, J. Randolph, Kim, Seung Tae, Koo, Dong-Hoe, Halani, Khalif, McAllister, E. Russell, Jones, Michelle, Snow, Malcolm, Lemmerick, Yasmin, Spera, Gonzalo, Pankovich, Jim |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p143-143, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|